Evaluating Whole Foods Supplementation on Cognition

Inclusion Criteria: * 60 years of age and older * English speaking * Not living in a skilled or intermediate care level nursing facility * No use of dietary supplements for cognitive functioning two weeks before enrolling in the study and during the length of the trial * A Mini-Mental State Exam (MMSE) score ≥ 23 Exclusion Criteria: * A cognitive deficit greater than that indicated according to the MMSE score * A clinical diagnosis of AD and/or related disorders * A psychiatric diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, major depression with psychotic features, delirium, and alcohol or substance abuse/dependence * Bleeding disorders * Aphasia or sensory, motor, and/or visual disturbances that would have interfered with psychometric tests * Gastrointestinal disorders causing impaired absorption of the study supplements * Insulin-dependent diabetes * Major conditions such as cardiovascular, pulmonary, renal, thyroid, hepatic, gastrointestinal, or seizure * Hematologic or oncologic disorders treated with chemotherapy in the previous two years * Active chemotherapy or radiation treatment for cancer * Current cigarette smoking * More than three major medical or psychiatric hospitalizations in the past year * Diagnosis of a terminal illness * A T score \> 70 on the Global Severity Index of the Brief Symptoms Inventory (BSI) * A score ≥ 29 on the Beck Depression Inventory-II (BDI) (15) * Prescription and OTC sympathomimetic amines and antihistamines within 2 days of an assessment visit * Cognition enhancing drugs consumption such as Donepezil, Rivastigmine, Galantamine, and Tacrine * Coumadin, tricyclic antidepressants, antipsychotics, and anticonvulsants * Cognition-enhancing supplements, herbs, or antioxidants that could not be stopped during the trial * Participating in a concurrent trial for drugs, supplements, or treatment that affects behavior or cognitive function